Michael Scolaro

Michael Scolaro

Sep 27, 2017

Group 6 Copy 116
2
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Making Inexpensive Insulin Using Microalgae

This page serves as an archive of our first proof-of-concept experiments to genetically modify microalgae...

A Modification to Homeopathic Drug Carcinosin

Cancer is linked to genetic mutations in hosts who are already genetically unique, which can make it seem...

Backer Badge Funded